Category: by reason for retraction

Sports columnist Reilly loses ESPN.com gig after replaying his work

Rick Reilly
Rick Reilly

Rick Reilly, a noted sports columnist, once wrote about football replays:

Tell me if I’m a crank, but do you notice that every time a football replay comes up—and I mean every time—the color guy goes, “OK, now watch this!” I mean, what else are we gonna do? Suddenly start knitting a sweater? Start collecting for UNICEF? You don’t need to tell us to watch the TV set we’re already watching! OK, maybe I am a crank.

But readers of Reilly might well have wondered why they were being subjected to replays of his work. His bosses at ESPN.com evidently did, because they’ve unplugged the writer’s keyboard in the wake of a self-plagiarism scandal, according to news reports. Such self-plagiarism — more accurately referred to as duplication — is of course a frequent reason for retractions.

Deadspin offers a nice side-by-side of the similarities between a recent Reilly column — titled, ironically, “Don’t act like you’ve been there” — and one from 2009, brought to the publication’s attention by a reader. Some examples: Continue reading Sports columnist Reilly loses ESPN.com gig after replaying his work

Why was that lung cancer paper retracted? The “authors’ reason,” of course

jthordisTwo researchers who wrote a review article on the genetics of lung cancer have retracted the paper. But why evidently is for them to know and us to find out.

The article, “Epigenetic aberrant methylation of tumor suppressor genes in small cell lung cancer,” was published in the August 2013 issue of the Journal of Thoracic Disease by authors from Shandong University in China.

According to the retraction notice: Continue reading Why was that lung cancer paper retracted? The “authors’ reason,” of course

In sharp resignation letter, former ORI director Wright criticizes bureaucracy, dysfunction

David Wright, via ORI
David Wright, via ORI

Last week, we reported that David Wright had resigned as director of the Office of Research Integrity (ORI). At the time, we noted we were short on details, but  Science has obtained Wright’s resignation letter, which sheds a great deal of light on the move.

In his letter, according to Science, Wright wrote that: Continue reading In sharp resignation letter, former ORI director Wright criticizes bureaucracy, dysfunction

Reverse peristalsis for gut journal which disgorges Cleveland Clinic paper for plagiarism

ajg_cimageThe American Journal of Gastroenterology has retracted a 2011 article on colon cancer by a group of Cleveland Clinic researchers after finding “evidence” of plagiarism in the text.

The article, a review, was titled “Molecular Pathways Underlying IBD-Associated Colorectal Neoplasia: Therapeutic Implications,” and has been cited 16 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the retraction notice: Continue reading Reverse peristalsis for gut journal which disgorges Cleveland Clinic paper for plagiarism

Researchers invent time machine! (But too late to avoid retraction for duplication)

compinterfaceA common theme in movies involving time travel is that if you meet yourself in the past, you’ll upset the time-space continuum, and cause all sorts of problems. Well, a group of materials scientists in Hong Kong seems to have invented a time machine, and learned that if if you publish a paper that appears to have been published in the future, you’ll suffer a retraction (and correction) for duplicating your own data.

We’ll (try to) explain.

The group in 1997 published a paper in Composite Interfaces titled “Reliability of fiber Bragg grating sensors embedded in textile composites.”

But now comes the following — inscrutable — Corrigendum: Continue reading Researchers invent time machine! (But too late to avoid retraction for duplication)

Senator “unsatisfied” with ORI’s response on recovery of tainted grant money

ori logoMarch has come in like a lion for the folks at the Office of Research Integrity (ORI).

The agency’s director, David Wright, stepped down late last month for reasons that even now remain unclear. And in what seems to be an unrelated development, ORI has managed to draw the ire of Sen. Charles Grassley, who has been among the staunchest watchdogs over federal research integrity.

According to the Des Moines Register, the Iowa Republican

Continue reading Senator “unsatisfied” with ORI’s response on recovery of tainted grant money

Not-so-tiny ethics issues as Micron retracts first-ever paper, and authors apologize for five duplicates

micronThe editors of the journal Micron — an Elsevier title — have retracted its first paper ever, and in an editorial marking the occasion, take on a number of issues in scientific publishing misconduct.

The beginning of the editorial (which is paywalled): Continue reading Not-so-tiny ethics issues as Micron retracts first-ever paper, and authors apologize for five duplicates

Co-author of controversial acid STAP stem cell papers in Nature requests retraction: report

nature 2-27-14A co-author of two papers claiming to have shown how to create stem cells simply and easily has requested their retraction, the Wall Street Journal is reporting: Continue reading Co-author of controversial acid STAP stem cell papers in Nature requests retraction: report

Office of Research Integrity (ORI) head David Wright leaves agency

wright
David Wright (via ORI)

David Wright has left his post as director of the Office of Research Integrity (ORI), Retraction Watch has learned.

Although we’re short on details on the moment, we have confirmed that Wright’s last day at the agency was a week ago Thursday. Wright joined ORI as director in January 2012. According to his agency bio:

Continue reading Office of Research Integrity (ORI) head David Wright leaves agency

“Critical data” errors force retraction of vision paper

jjophthalA group of authors in Korea has lost their 2013 paper on treating vision loss after one of the two cases they’d reported turned out to have been fatally flawed.

The paper, “Isolated central retinal artery occlusion as an initial presentation of paroxysmal nocturnal hemoglobinuria and successful long-term prevention of systemic thrombosis with eculizumab,” had appeared in the Japanese Journal of Ophthalmology.

According to the abstract: Continue reading “Critical data” errors force retraction of vision paper